Affordably Source Pharma Experts and Industry Participants for Market Research, Diligence and Projects

Submit an anonymous Project Description -- Start receiving responses within a few hours

Have a need? Explain it here






How Zintro Works

  1. 1. Provide a clear description of your needs and your expectations of an expert, consultant or job candidate and Zintro will match it with the most relevant professionals in our platform.
  2. 2. Within a day or two typically 6 - 12 Experts, who have opted-in, will contact you with a brief explanation of their qualifications and how they can help.
  3. 3. You can communicate back and forth, qualify each other, connect and pay fees to Experts through Zintro.
  4. Zintro is free, anonymous and without obligation.

Loved by Thousands

Loved by thousands logos

Need Help?A phone icon1-877-236-7016

Recent Pharma Inquiries

Area Icon

Pharma Qualitative Study

We are seeking highly specialized experts with experience in the life sciences industry - must meet below specifications location: usa - san fransisco bay area, los angeles, philadelphia, new york, boston. Industry: pharmaceuticals, contract development and manufacturing organizations (cdmos)/clinical research organizations (cros), and life science market research. Testing availability: late june - early july study 2: qualitative study - one on one either telephonic or in-person interviews **respondent profile**: cost estimates for both tdi (telephonic interviews) and idi (in person interviews) with 8 respondents, 2 each from clinical trial supply managers/coordinators/directors, procurement contacts / outsourcing managers / directors, clinical / pre-clinical teams, senior executives (pharma/biotech/cro) **expert's job titles**: 1) clinical trial supply managers / coordinators / directors 2) procurement contacts / outsourcing managers / directors 3) clinical / pre-clinical teams 4) senior executives **experts must have a clear understanding of the following topics (doesn't have to be an expert at each level, but at least one, also a basic understanding of others)**: a. Api services & chemical development – all stages of drug development for small molecules, potent and cytotoxic compounds, and peptides b. Pharmaceutical development – development cycle of clinical candidate into an optimum formulation and clinical stages manufacturing c. Analytical services – analytical services supporting drug substance (api) and drug product development including cmc regulatory filings d. Clinical trial supply – clinical supplies, packaging, distribution and delivery of clinical protocols, supply chain management. E. Clinical technologies - solutions for patient enrollment, screening randomization, drug assessment etc. F. Commercial services – api supply, manufacturing, testing and packaging to end-user distribution.

  1. Profile Picture

    Jukka |President, Director

    Can cover almost every area in detail. Been involved and leading development for 30 years. Would be ...

    29 Minutes Later
  2. Profile Picture

    Scott |Sr. Technical Services Project Engineer

    I am involved in most of the areas you need help with. I oversee all of our 3rd parties. Let me kn...

    36 Minutes Later
  3. Profile Picture

    Mohamed |Zintro Expert

    I am ***** Organe county area and happy to help with the project. Being global team lead for d...

    42 Minutes Later
+18 Other Responses
Area Icon

Heor | Pharma & Vendor Perspective

We’re looking to speak with 2 experts (one from a pharma company and one from a vendor) to begin with who have a good idea about outsourcing opportunities present within the heor (health economics and outcomes research) segment. This would be for a 1 - hour paid phone consult. Please respond with a few brief statements as to your relevance in this space. 1. Can you discuss the different services within the heor function and who are the key players in europe/us? 2. Would you be able to explain the spend by phase/activity/expected peak sales/company size a. For example: what is the spend on rwe/rwd analysis and htas by phase/peak sales of a given molecule 3. Can you share your insights on mega trends/tech disruption in the segment because of ai/ml a. How has the market evolved over the last 3 years and where is it headed in the coming 3 years? Companies: novartis, pfizer, jazz pharmaceuticals, allergan, amgen, celgene vendors: parexel, evidera, iqvia, drg, laser analytica note: we are looking to speak only with us/eu experts.

  1. Profile Picture

    Jinender |Associate Director

    I could provide an industry perspective on the above questions. I have more than 10 years of experie...

    8.3 Hours Later
  2. Profile Picture

    Earl |MD

    I do not have expertise in this field ...

    8.3 Hours Later
  3. Profile Picture

    Stephanie |Senior Director

    I would be happy to talk to you about the direction that HEOR and *****ices are heading. I ha...

    9.5 Hours Later
+37 Other Responses
Area Icon

Life Science Procurement Maturity

We are a global research and advisory firm and are seeking experts who can assist us with insights (both qualitative and quantitative) on the maturity of procurement as a function across countries / regions. This entails providing us with comparative data / benchmarks that help indicate the maturity of countries in terms of their procurement practices. The applicable industry is life sciences. The list of regions and countries include: in western europe: germany, france, uk, holland, spain, italy, switzerland, belgium, (norway & finland nice to have but not mandatory) in apac: india, china, singapore (australia nice to have but not mandatory) in latam: brazil, argentina, colombia, mexico we would like to engage via phone consult with experts knowledgeable on the aforementioned topic. We are looking for a phone consult for a time period of 1-2 hours to discuss the same. Please supplement your expression of interest with an indication of the approach that you are likely to adopt to answer the aforementioned question. Regards, budha

  1. Profile Picture

    Polina |Oversight & Monitoring Lead, Health Care

    Hi Budha, I can discuss this topic for the U.S. Market. Best, Polina...

    10.1 Hours Later
  2. Profile Picture

    Gaurav |Pharmaceutical Quality Systems Consultan

    Good Day I have over twenty years of Industry experience and can specifically help you with this co...

    12.8 Hours Later
  3. Profile Picture

    John |Industrial MRO Spares sourcing and Consu

    Hello, I have been tracking the indirects procurement ***** life science industry for the ...

    15.7 Hours Later
+13 Other Responses
Area Icon

Impact Of Covid 19 On Sales & Marketing For Pharma

We are looking to speak with multiple experts based in the us that has significant input into the effect of covid 19 in sales for pharma companies. Looking to speak with experts in neurology, psychiatry, pulmonology. I’m interested in having conversations with people who are in sales/marketing for these companies in the us. This is a paid 1-hour phone consultation. Please provide a brief response below as to your relevance in the space. 1. Can you discuss a brief statement on how covid 19 impacts the sales of your company?

  1. Profile Picture

    Lewis |Retired - Was Pharmaceutical Specialty R

    Yes, I can give you an *****ysis on how COVID 9 will and is affecting sales, especially in t...

    15 Hours Later
  2. Profile Picture

    Tom |District Sales Manager

    I cam easily discuss at length now we have been impacted by covid. Our sales force has temporally tr...

    21.3 Hours Later
  3. Profile Picture

    Susan |Distict Sales Manager

    1. Can you discuss a brief ***** how COVID 19 impacts the sales of your company? --> Yes, I c...

    21.6 Hours Later
+82 Other Responses
Area Icon

Pharma Research Interviewees

We are seeking highest specialized experts with experience in the life sciences industry - must meet below specifications location: usa - san fransisco bay area, los angeles, philadelphia, new york, boston. Industry: pharmaceuticals, contract development and manufacturing organizations (cdmos)/clinical research organizations (cros), and life science market research. Testing availability: late june - early july study 1: qualitative study - focus group interviews with 3 groups (6-8 respondents per group) **respondent profile**: group 1: 6-8 pharmaceutical executives from top 20 biotech companies who are influencers, contributors or decision makers on outsourcing services to contract development and manufacturing organizations (cdmos)/clinical research organizations (cros). Group 2: 6-8 pharmaceutical executives from top 10 clinical research organizations (cros) companies who are influencers, contributors or decision makers on outsourcing services to contract development and manufacturing organizations (cdmos)/contract research organizations. Group 3: 6-8 pharmaceutical executives from small / mid-sized pharmaceutical companies who are influencers, contributors or decision makers on outsourcing services to contract development and manufacturing organizations (cdmos)/contract research organizations. **expert must have** a clear understanding of the following topics (doesn't have to be an expert at each level, but at least one, also a basic understanding of others): a. Api services & chemical development – all stages of drug development for small molecules, potent and cytotoxic compounds, and peptides b. Pharmaceutical development – development cycle of clinical candidate into an optimum formulation and clinical stages manufacturing c. Analytical services – analytical services supporting drug substance (api) and drug product development including cmc regulatory filings d. Clinical trial supply – clinical supplies, packaging, distribution and delivery of clinical protocols, supply chain management. E. Clinical technologies - solutions for patient enrollment, screening randomization, drug assessment etc. F. Commercial services – api supply, manufacturing, testing and packaging to end-user distribution.

  1. Profile Picture

    Jukka |President, Director

    My experience covers all areas over 30 years. Have a look at my profile. I have recently consulted o...

    27 Minutes Later
  2. Profile Picture

    Scott |Sr. Technical Services Project Engineer

    I am involved in most of the areas you need help with. I oversee all of our 3rd parties. Let me kno...

    45 Minutes Later
  3. Profile Picture

    Kuldeepak |Director

    Thanks for your message. As a pharmaceutical consultant & Ph.D. in pharmaceutics, I have extensive h...

    53 Minutes Later
+15 Other Responses
Area Icon

Pharma Contract Sales In India & China

Looking to understand the market for contract sales organizations (cso), primarily in india and china. I would like discuss further on the following topics: • suppliers landscape - how mature is the supply base for these services? What is the % adoption rate for these services when compared to markets like eu, us? - who are the major players in india and china? Are there any major global players operating in these markets? • what is the outlook for these services? What is driving the adoption of these services? What are the potential challenges? • case studies highlighting collaboration between major pharma companies and cso's in these geographies

  1. Profile Picture

    Frank |President

    I have 28 years of experience and knowledge with a detail understanding working as a consultant t...

    3.9 Hours Later
  2. Profile Picture

    Oscar |

    I am experi pharmaceutical business consultant with extensive global network footprint to provide th...

    4.7 Hours Later
  3. Profile Picture

    Polina |Oversight & Monitoring Lead, Health Care

    I can discuss comparisons of CSO services between Indian markets and those of US, including adoption...

    10.1 Hours Later
+6 Other Responses
Area Icon

Pharma & Agrochemical Formulated Products

We are looking for industry experts who will be able to help us in a study about manufacturing formulated products for pharma and agrochemical markets. Specific questions are - 1. What are currently the main trends with respect to the manufacturing of pharma and agrochemical formulated products? 2. What country/region, are currently leading the way in pharma/agrochemical formulated products manufacturing and why 3. What are the big players strategy in pharma/agrochemical formulated products manufacturing today and tomorrow and why; are they producing in house or do they prefer to outsource? Is it possible to highlight a trend and a reason? 4. What can we expect in the next 3-5 years, with respect to pharma / agrochemical formulated products manufacturing and/or outsourcing of manufacturing? 5. What improvements/process have been implemented in order to make the outsourcing of pharma/agrochemical formulated product manufacturing a viable option? 6. What are the gaps and the similarity between the big pharma and the big agrochemical players in terms of agrochemical formulated products manufacturing? Please respond at the earliest and we can take it forward. Regards, virat

  1. Profile Picture

    Jim |Director

    Hello, I believe that we could help you ***** your enquiry. ***** a specialist consul...

    5 Hours Later
  2. Profile Picture

    Sarita |Pharma Regulatory Consultant

    Hi Virat I can support you in this project for Pharma products. I have around 20 years experience i...

    6.5 Hours Later
  3. Profile Picture

    A.V.N. |M&A Consultant

    Hi Virat , I can give you the best . avn ...

    7.7 Hours Later
+42 Other Responses
Area Icon

Travel Policy Benchmarking Of Indian Pharma

Travel policy benchmarking of pharmaceuticals & healthcare companies in india we are a global market research firm seeking experts who can assist us by providing insights on the travel policies of leading pharmaceuticals & healthcare companies in the india region. We would wish to seek expert insights on the following aspects: 1. Case references of travel policies of leading pharmaceutical companies in india: • case studies on travel policies of key pharma companies related to maintaining quality standards, limits for metros and non-metro cities across india • details about tie-ups between key hotel chains in india and leading pharma companies across tier 1, tier 2 and tier 3 cities and benefits of such tie-ups 2. Insights on threshold values defined by leading pharma companies in india based on the following: • employee levels: threshold limits based on employee designations • class of the destination city: tier1, tier2, tier3 cities • star ratings of the hotels' booked: 3 star, 4 star, 5 star 3. Best practices • guidelines and kpis on business hotel selection in indian cities • best practices to be adopted for increased savings while designing a travel policy by various pharma companies based on various cities, hotel chains and employee thresholds, for the india region 4. Insights pertaining to hotel booking policies of top pharma companies in india, with respect to policy elements such as: • hotel price ranges, mode of payment • minimum days requirement for advance hotel booking • type of fare preferred for example pre-payment/non-refundable rates etc. • reimbursement of following: a. Cancellation charges – before deadline b. Extended stay option c. Dry cleaning & laundry charges d. Access to amenities [gym, spa] charges e. Hotel frequent usage program f. Room upgrades g. “no-show” charges [cancellation occurs after deadline or failure to cancel] 5. Insights pertaining to air travel policies of top pharma companies in india, with respect to policy elements such as: • air travel management company [tmc] engaged • preferred advance ticket booking window (7 days or 14days for example) • class of service such as economy class, business class, premium economy/economy comfort/equivalent to list a few • preferred type of ticket: for example, lowest restricted, non-refundable fare • reimbursement on flight upgrades and permissible flight upgrade limits • benefits on downgrading to lower class • criteria for the prohibition on international travel approvals if any • executive risk exposure (restrictions on traveling of employees based on designation, group or any maximum number, etc. • reimbursements of other auxiliary policy elements such as airline club memberships, in-flight charges [baggage], frequent flyers program, overnight delays & cancellation of air travel, airline incidentals [pillows, blankets, headsets, etc.], passport, visa & immigration charges, weekend stays, mode of payment 6. Insights pertaining to car rental policies of top pharma companies in india, with respect to policy elements such as: • car models based on class of service/travelers #, such as intermediate/mid-size, large car/mini-van, suvs, etc. • eligibility for using rental car based on distance traveled • reimbursement of refueling of rental car before handing over, maintenance & repair • availability of pre-pay fuel option, one-way rental option • reimbursement of delayed return charges, toll booth charges • preferred mode of payment • insurance coverage • rental car upgrades reimbursement 7. Reimbursements of other travel expenses such as: • child care expenses, currency exchange charges, dependent travel [spouse, guest, domestic partner, etc.], medical requirements while travelling, business travel accident insurance, to list a few

  1. Profile Picture

    Anand |Chief Consultant -Training and Developme

    Let's connect on ***** or Microsoft Teams or any other ***** take this forward. Please mail...

    4.1 Hours Later
  2. Profile Picture

    Vipin |Consultant Technical Support

    Travel policies has ***** every Pharma company in India subject to the size of companies. Ho...

    4.4 Hours Later
  3. Profile Picture

    Kuldeep (Mr) |Pharmaceutical Consultant

    I am available for the discussion....

    9.7 Hours Later
+16 Other Responses
Area Icon

Pharma Capital Equipment

This is in regard with a new requirement coming from a global pharmaceutical and life science company. They presently have requirement on market understanding and technology/ trends understanding for their pharma capex requirement. The below mentioned capex equipment are our focus 1. Bioreactors/ fermenters- stainless steel (ss) bioreactors 2. Process skids- purification & media & buffer preparation, chromatography, uf/df/tff, cip, wfi/purified water 3. Isolators 4. Freeze dryers 5. Inspection equipment we are looking for expert who are there in this field of sourcing pharma capex of above mentioned equipment list. We are looking for experts who have a decade long experience on the same. Some of the deliverables are mentioned below 1. Technology / innovations happening across each parent equipment category mentioned above 2. Any recent government regulation in europe or united states that impact any of the equipment category and the suppliers associated with this? 3. Market outlook for any of the equipment, market trends and supplier/ buyer trends in this space 4. Best practices on sourcing for capex pharma equipment as a category- sourcing model, engagement model, contract structure etc 5. Input cost structure on each of the equipment- engg and manufacturing cost structure 6. Approx. Leadtime that is expected for each equipment 7. Covid 19 impact on pharma capex equipment as a category kindly let us know if you need any queries on the same. Regards

  1. Profile Picture

    Jaume |CEO

    Dear Sirs, I guess I can assist you on this; I'm a chemist and biochemist with more than 35 years of...

    4.5 Hours Later
  2. Profile Picture

    Arunava |Corporate Quality Intelligence

    I have done recently multiple projects on overall biopharma USP /DSP and clean and black utilities C...

    5.5 Hours Later
  3. Profile Picture

    Veeramani |Head-Mktg

    I am an microbial biotechnologist, having 28 years experience in business.And i am sure that i can h...

    2.2 Days Later
+6 Other Responses
Area Icon

Pharma Sales Meetings

We are looking for experts to help us understand: who are the suppliers who conduct sales meetings for medium and large pharmaceutical companies in us? Who are the suppliers who conduct sales meetings for companies other than pharmaceuticals having large sales staff in us? What are the trends for pharma sales meetings? Do suppliers require a specialization in conducting pharma meetings? Do pharmaceutical companies use the same vendor for sales meeting logistics and for training content development?

  1. Profile Picture

    Tonya |Zintro Expert

    I am a medical assistant and formally worked for the NY Health and Hospitals corporation. I have an ...

    3.8 Hours Later
  2. Profile Picture

    Tom |Company President

    Hello.. please give me a call.. I'm Tom Pasha, President of CONTACT Planning Inc., a contracted mee...

    3.8 Hours Later
  3. Profile Picture

    Betsy |President

    I have been in the pharma meetings industry for 20+ years. I am a recognized Subject *****rt (...

    6 Hours Later
+9 Other Responses
Area Icon

Pharma/biotech Insights And Analytics

We are looking to do multiple paid phone consultations to gain a better understanding of the insights and analytics of major pharma and biotech companies such as sanofi, johnsons & johnsons, bristol meyers squibb, pfizer, merck. We would be particularly interested to speak with senior executives responsible for analyzing insights and data around marketing. Examples include early patient identification, patient journey, action analytics, integrated forecasting, market research, commercial analytics, sales force effectiveness, etc. Ideally someone in a decision-making capacity or heavily influential to decision making in terms of marketing analytics from the pharmaceutical companies mentioned above. Also, senior-level people from major data analytics companies engaged in life sciences such as mu sigma, shyft analytics, etc. Responsible for platforms around pharma analytics/insights or rwe focused technology platforms. This would be for a 1-hour paid phone consult. To demonstrate your relevance, please consider briefly answering the questions below: 1. What is the extent of your experience that will showcase your overall knowledge in handling marketing insights and analytics for pharma and/or biotech products/companies? Please answer briefly. 2. Which providers or consultants do you currently use to obtain marketing insights and analytics (e.G. Mu sigma, shyft analytics, axtria, analytical wizards, etc.)? If you do not actively use them are you aware of the different marketing insights and analytics companies/platforms? 3. Are you familiar or knowledgeable with any of the following analytics software company: mu sigma, shyft analytics, analytical wizards, or axtria? Kindly specify. ***referrals are highly appreciated.

  1. Profile Picture

    Gaurav |Pharmaceutical Quality Systems Consultan

    With over 23 years of industry experience with companies like Johnson abd Johnson, I csn certainly ...

    1.4 Hours Later
  2. Profile Picture

    Jenine |Health Systems Management and Transition

    I am interested in the opportunity. I have worked within and cross functionally with marketing busin...

    1.7 Hours Later
  3. Profile Picture

    Ehab |Zintro Expert

    I’m interested in this opportunity, actually I worked for Sanofi for about 13 years& with experience...

    3.7 Hours Later
+15 Other Responses
Area Icon

Public Cloud Infrastructure For Life Sciences

Our client would like to speak with multiple life sciences decision-makers in the us who have influence in determining the it infrastructure on which their company’s it workloads are deployed and have roles in reviewing/approving major it purchasing decisions. They are aiming to better understand the different types of major it or it infrastructure purchases. This is a 1-hour paid phone consultation. If open to participating, please provide a brief answer to the question below: at work, do you have significant business decision-making authority for…? Your organization as a whole multiple departments or divisions your own department or division only a team within your department or division only you do not have decision-making authority

  1. Profile Picture

    Prasad |VP ML & AI and Distinguished Engineer

    I have significant business decision-making authority for Healthcare Cloud infra, PaaS and SaaS host...

    53 Minutes Later
  2. Profile Picture

    Bhupesh |DIRECTOR, PRODUCT MANAGEMENT & MARKETING

    my experience with cloud service providers and life sciences orgs is right for this discussion...

    1 Hour Later
  3. Profile Picture

    Poonam |Vice President - IT and Cybersecurity

    I am the primary decision maker for all our IaaS/PaaS/SaaS cloud infrastructure and ***** ...

    1.5 Hours Later
+40 Other Responses
See More Inquiries

Top Pharma Experts

See More Experts
Share
LinkedInTwitterFacebookGoogle+